Cargando…

RT‐CGM in conjunction with CSII vs MDI in optimizing glycaemic control in T1DM: Systemic review and meta‐analysis

INTRODUCTION: To determine the impact of real‐time continuous glucose monitoring (RT‐CGM) in conjunction with ‘Open loop’‐ continuous subcutaneous insulin infusion (CSII) as compared to conventional multiple daily injections (MDI) in type 1 diabetes. METHODS: We explored the COCHRANE database, MEDLI...

Descripción completa

Detalles Bibliográficos
Autores principales:	William, Jimmy, McCluskey, Jane, Gleeson, Nigel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917862/ https://www.ncbi.nlm.nih.gov/pubmed/35118826 http://dx.doi.org/10.1002/edm2.324

Ejemplares similares

Postnatal growth of infants with neonatal diabetes: Insulin pump (CSII) versus Multiple Daily Injection (MDI) therapy
por: Alyafie, Fawzia, et al.
Publicado: (2019)

Clinical Outcome and Cost-Effectiveness Analysis of CSII Versus MDI in Children and Adolescent With Type 1 Diabetes Mellitus in a Public Health Care System of China
por: Hu, Sicui, et al.
Publicado: (2021)

Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control
por: Senn, Jon-Duri, et al.
Publicado: (2019)

HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment
por: Scott, Emma S, et al.
Publicado: (2019)

Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial
por: Lawson, Margaret L., et al.
Publicado: (2020)

CLIC MDI Overview
por: Gatignon, Lau
Publicado: (2012)

CLIC MDI Overview
por: Gatignon, Lau
Publicado: (2012)

Monte Carlo Driven MDI Optimization at a Muon Collider
por: Curatolo, Camilla, et al.
Publicado: (2021)

Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections
por: Sofizadeh, Sheyda, et al.
Publicado: (2019)

Study protocol: glycaemic outcomes in people with type 2 diabetes initiating continuous glucose monitoring: the 2GO-CGM study
por: Lever, Claire S., et al.
Publicado: (2023)

Comparison of Glucose Metrics Between Users of CGM Readers and CGM-Connected Apps
por: Kao, Kalvin, et al.
Publicado: (2021)

(Selected) MDI Issues of ILD
por: Pöschl, Roman
Publicado: (2020)

MDI Experience from the ILC
por: Buesser, Karsten
Publicado: (2007)

CSII treatment as an option in high-risk pregnant patients with type 1 diabetes
por: Breder, Íkaro Soares Santos, et al.
Publicado: (2015)

Sensor-augmented CSII therapy with predictive low-glucose suspend following total pancreatectomy
por: Scott, E S, et al.
Publicado: (2017)

Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma
por: Morice, A H, et al.
Publicado: (2007)

Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes
por: Pettus, Jeremy, et al.
Publicado: (2016)

CGM in the Hospital: Is It Ready for Prime Time?
por: Buschur, Elizabeth O., et al.
Publicado: (2022)

Mouse-Derived Isograft (MDI) In Vivo Tumor Models I. Spontaneous sMDI Models: Characterization and Cancer Therapeutic Approaches
por: Jantscheff, Peter, et al.
Publicado: (2019)

Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study (§)
por: Préau, Yannis, et al.
Publicado: (2021)

Heterogeneity of Responses to Real-Time Continuous Glucose Monitoring (RT-CGM) in Patients With Type 2 Diabetes and Its Implications for Application
por: Fonda, Stephanie J., et al.
Publicado: (2013)

The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM
por: Renard, Eric, et al.
Publicado: (2021)

Mouse-Derived Isograft (MDI) In Vivo Tumor Models II. Carcinogen-Induced cMDI Models: Characterization and Cancer Therapeutic Approaches
por: Beshay, Janette, et al.
Publicado: (2019)

SAT-649 Comparison of the Accuracy and Concordance of 3 CGM Devices vs SMBG During Aerobic Exercise
por: Henske, Joseph A, et al.
Publicado: (2020)

Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes
por: Lyu, Fu-ping, et al.
Publicado: (2020)

Effect of Acetaminophen on CGM Glucose in an Outpatient Setting
por: Maahs, David M., et al.
Publicado: (2015)

Summary of the BDS and MDI CLIC08 Working Group
por: Tomás, R, et al.
Publicado: (2008)

Finite Elements Magnetic Analysis of the CLIC MDI Region
por: Bartalesi, Antonio
Publicado: (2012)

Adaptability of structured forms for CSII initiation in patients with type 2 diabetes the Getting2Goal(SM) concept
por: Cohen, O., et al.
Publicado: (2016)

Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy
por: Li, Feng-fei, et al.
Publicado: (2018)

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
por: King, Allen B., et al.
Publicado: (2016)

Development and validation of an instrument (CSII – Brazil) to assess users’ conceptual and procedural knowledge of continuous subcutaneous infusion systems
por: Amaral, Camilla Magalhães de Oliveira, et al.
Publicado: (2020)

Effects of low glycaemic index/low glycaemic load vs. high glycaemic index/ high glycaemic load diets on overweight/obesity and associated risk factors in children and adolescents: a systematic review and meta-analysis
por: Schwingshackl, Lukas, et al.
Publicado: (2015)

Indigenous device for in circuit delivery of bronchodilator drugs through MDI
por: Singh, Balkar, et al.
Publicado: (2010)

COVID-19: Time to embrace MDI+ valved-holding chambers!
por: Amirav, Israel, et al.
Publicado: (2020)

Assessing the use of MDI among asthmatic patients in Saudi Arabia
por: Abougalambou, Salwa Selim, et al.
Publicado: (2022)

CGM and CGI: metafile and interface standards for computer graphics
por: Arnold, David B, et al.
Publicado: (1988)

Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials
por: Cappelletti, Christy, et al.
Publicado: (2021)

Longitudinal analysis of users transitioning from the Dexcom G5 to the G6 RT‐CGM system in Germany, Sweden and the United Kingdom (2018–2020)
por: Acciaroli, Giada, et al.
Publicado: (2022)

Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446]
por: Cavan, David A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1trd6eda2f06n9t1rpa4f2dqbd